Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![DailyMonitor Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::35697740.png) Daily Monitor [@DailyMonitor](/creator/twitter/DailyMonitor) on x 2M followers
Created: 2025-06-19 17:01:27 UTC

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences GILD.O lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.

#MonitorUpdates

![](https://pbs.twimg.com/card_img/1935744747173257216/fxhRDuWs?format=jpg&name=800x419)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1935744751514665032/c:line.svg)

**Related Topics**
[gilead sciences](/topic/gilead-sciences)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/DailyMonitor/status/1935744751514665032)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

DailyMonitor Avatar Daily Monitor @DailyMonitor on x 2M followers Created: 2025-06-19 17:01:27 UTC

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences GILD.O lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.

#MonitorUpdates

XXXXXX engagements

Engagements Line Chart

Related Topics gilead sciences stocks healthcare

Post Link

post/tweet::1935744751514665032
/post/tweet::1935744751514665032